NewAmsterdam Pharma Corporation Employee Directory
Biotechnology ResearchFlorida, United States51-200 Employees
NewAmsterdam Pharma Corporation is a biotechnology research company based in Aventura, Florida, founded in 2019. It operates in late-stage clinical development focused on therapies for cardiometabolic diseases. The company is pursuing an oral, non-statin LDL-C-lowering therapy for patients who do not achieve adequate control with current treatments or cannot tolerate them, including those with ASCVD or familial hypercholesterolemia on maximally tolerated statin therapy. A key area of investigation is a selective CETP inhibitor intended to reduce LDL-C. In June 2026, the company announced it would present data on obicetrapib at the National Lipid Association Scientific Sessions.